Literature DB >> 30288684

The Depression Treatment Cascade: Disparities by Alcohol Use, Drug Use, and Panic Symptoms Among Patients in Routine HIV Care in the United States.

Bethany L DiPrete1, Brian W Pence2, Angela M Bengtson2, Richard D Moore3, David J Grelotti4, Conall O'Cleirigh5,6, Riddhi Modi7, Bradley N Gaynes8.   

Abstract

Little is known about disparities in depression prevalence, treatment, and remission by psychiatric comorbidities and substance use among persons living with HIV (PLWH). We conducted a cross-sectional analysis in a large cohort of PLWH in routine care and analyzed conditional probabilities of having an indication for depression treatment, receiving treatment, receiving indicated treatment adjustments, and achieving remission, stratified by alcohol use, illicit drug use, and panic symptoms. Overall, 34.7% (95% CI 33.9-35.5%) of participants had an indication for depression treatment and of these, 55.3% (53.8-56.8%) were receiving antidepressants. Among patients receiving antidepressants, 33.0% (31.1-34.9%) had evidence of remitted depression. In a subsample of sites with antidepressant dosage data, only 8.8% (6.7-11.5%) of patients received an indicated treatment adjustment. Current drug users (45.8%, 95% CI 43.6-48.1%) and patients reporting full symptoms of panic disorder (75.0%, 95% CI 72.9-77.1%) were most likely to have an indication for antidepressant treatment, least likely to receive treatment given an indication (current drug use: 47.6%, 95% CI 44.3-51.0%; full panic symptoms: 50.8%, 95% CI 48.0-53.6%), or have evidence of remitted depression when treated (22.3%, 95% CI 18.5-26.6%; and 7.3%, 95% CI 5.5-9.6%, respectively). In a multivariable model, drug use and panic symptoms were independently associated with poorer outcomes along the depression treatment cascade. Few differences were evident by alcohol use. Current drug users were most likely to have an indication for depression treatment, but were least likely to be receiving treatment or to have remitted depression. These same disparities were even more starkly evident among patients with co-occurring symptoms of panic disorder compared to those without. Achieving improvements in the depression treatment cascade will likely require attention to substance use and psychiatric comorbidities.

Entities:  

Keywords:  Alcohol drinking; Anxiety disorders; Depression; Drug users; HIV infections

Mesh:

Substances:

Year:  2019        PMID: 30288684      PMCID: PMC6408290          DOI: 10.1007/s10461-018-2282-3

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  46 in total

Review 1.  Efficacy of antidepressant medication among HIV-positive individuals with depression: a systematic review and meta-analysis.

Authors:  Seth Himelhoch; Deborah R Medoff
Journal:  AIDS Patient Care STDS       Date:  2005-12       Impact factor: 5.078

2.  Meta-analysis of the relationship between HIV infection and risk for depressive disorders.

Authors:  J A Ciesla; J E Roberts
Journal:  Am J Psychiatry       Date:  2001-05       Impact factor: 18.112

3.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

4.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

5.  Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States.

Authors:  E G Bing; M A Burnam; D Longshore; J A Fleishman; C D Sherbourne; A S London; B J Turner; F Eggan; R Beckman; B Vitiello; S C Morton; M Orlando; S A Bozzette; L Ortiz-Barron; M Shapiro
Journal:  Arch Gen Psychiatry       Date:  2001-08

6.  Re-estimating the prevalence of psychiatric disorders in a nationally representative sample of persons receiving care for HIV: results from the HIV Cost and Services Utilization Study.

Authors:  Maria Orlando; M Audrey Burnam; Robin Beckman; Sally C Morton; Andrew S London; Eric G Bing; John A Fleishman
Journal:  Int J Methods Psychiatr Res       Date:  2002       Impact factor: 4.035

7.  Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic.

Authors:  Gregory M Lucas; Kelly A Gebo; Richard E Chaisson; Richard D Moore
Journal:  AIDS       Date:  2002-03-29       Impact factor: 4.177

8.  The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility.

Authors: 
Journal:  Addiction       Date:  2002-09       Impact factor: 6.526

9.  SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis.

Authors:  A Bakker; A J L M van Balkom; P Spinhoven
Journal:  Acta Psychiatr Scand       Date:  2002-09       Impact factor: 6.392

10.  Underdiagnosis of depression in HIV: who are we missing?

Authors:  Steven M Asch; Amy M Kilbourne; Allen L Gifford; M Audrey Burnam; Barbara Turner; Martin F Shapiro; Samuel A Bozzette
Journal:  J Gen Intern Med       Date:  2003-06       Impact factor: 5.128

View more
  7 in total

Review 1.  Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.

Authors:  Stephanie M Matt; Peter J Gaskill
Journal:  Brain Res       Date:  2019-08-21       Impact factor: 3.252

2.  Achieving national HIV prevention goals: the case for addressing depression and other mental health comorbidities.

Authors:  Linda J Koenig; Lela R McKnight-Eily
Journal:  AIDS       Date:  2021-10-01       Impact factor: 4.632

3.  Operationalizing a Behavioral Health Services Cascade of Care Model: Lessons Learned from a 33-Site Implementation in Juvenile Justice Community Supervision.

Authors:  Michael L Dennis; Corey N Smith; Steven Belenko; Danica Knight; Larkin McReynolds; Grace Rowan; Richard Dembo; Ralph DiClemente; Angela Robertson; Tisha Wiley
Journal:  Fed Probat       Date:  2019-09

4.  A call to action: strengthening the capacity for data capture and computational modelling of HIV integrated care in low- and middle-income countries.

Authors:  Linda E Kupfer; Blythe Beecroft; Cecile Viboud; Xujing Wang; Pim Brouwers
Journal:  J Int AIDS Soc       Date:  2020-06       Impact factor: 5.396

5.  Depression and HIV viral nonsuppression among people engaged in HIV care in an urban clinic, 2014-2019.

Authors:  Catherine R Lesko; Heidi E Hutton; Anthony T Fojo; Nicola M Shen; Richard D Moore; Geetanjali Chander
Journal:  AIDS       Date:  2021-10-01       Impact factor: 4.632

6.  Patient-level predictors of detection of depressive symptoms, referral, and uptake of depression counseling among chronic care patients in KwaZulu-Natal, South Africa.

Authors:  Christopher G Kemp; Ntokozo Mntambo; Max Bachmann; Arvin Bhana; Deepa Rao; Merridy Grant; James P Hughes; Jane M Simoni; Bryan J Weiner; Sithabisile Gugulethu Gigaba; Zamasomi Prudence Busisiwe Luvuno; Inge Petersen
Journal:  Glob Ment Health (Camb)       Date:  2020-07-21

7.  A retrospective analysis of the care cascades for non-communicable disease and mental health among people living with HIV at a tertiary-care centre in Malaysia: opportunities to identify gaps and optimize care.

Authors:  Chong Meng Li; Fong Jie Ying; Dhevann Raj; Wong Pui Li; Anjanna Kukreja; Sharifah Fs Omar; Adeeba Kamarulzaman; Reena Rajasuriar
Journal:  J Int AIDS Soc       Date:  2020-11       Impact factor: 5.396

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.